Oridion Announces Significant Medical Research To Be Presented At AARC Congress

Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) announced that three substantial medical research project findings will be presented at the upcoming AARC (American Association for Respiratory Care) Congress in Anaheim, California. These studies confirm the clinical benefits of End-tidal CO2 (EtCO2) monitoring using Oridion Microstream(R) capnography technology and clearly show that capnography needs to be included in a hospital’s respiratory monitoring strategy.

More: continued here

Filed under: Conferences on December 11th, 2008